BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9502170)

  • 1. Effects of isoenzyme selective phosphodiesterase inhibitors on bacterial lipopolysaccharide-induced bronchial hyperreactivity in guinea pigs.
    Uno T; Tanaka H; Nagai H
    Gen Pharmacol; 1998 Feb; 30(2):167-73. PubMed ID: 9502170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs.
    Santing RE; Olymulder CG; Van der Molen K; Meurs H; Zaagsma J
    Eur J Pharmacol; 1995 Feb; 275(1):75-82. PubMed ID: 7774665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs.
    Howell RE; Sickels BD; Woeppel SL
    J Pharmacol Exp Ther; 1993 Feb; 264(2):609-15. PubMed ID: 8437112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.
    Underwood DC; Kotzer CJ; Bochnowicz S; Osborn RR; Luttmann MA; Hay DW; Torphy TJ
    J Pharmacol Exp Ther; 1994 Jul; 270(1):250-9. PubMed ID: 8035322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of inhibitors of phosphodiesterase, on antigen-induced bronchial hyperreactivity in conscious sensitized guinea-pigs and airway leukocyte infiltration.
    Danahay H; Broadley KJ
    Br J Pharmacol; 1997 Jan; 120(2):289-97. PubMed ID: 9117122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor.
    Raeburn D; Underwood SL; Lewis SA; Woodman VR; Battram CH; Tomkinson A; Sharma S; Jordan R; Souness JE; Webber SE
    Br J Pharmacol; 1994 Dec; 113(4):1423-31. PubMed ID: 7889300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of theophylline and rolipram on antigen-induced airway responses in neonatally immunized rabbits.
    Gozzard N; Herd CM; Blake SM; Holbrook M; Hughes B; Higgs GA; Page CP
    Br J Pharmacol; 1996 Apr; 117(7):1405-12. PubMed ID: 8730732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of interleukin-10 and modulators of cyclic AMP formation on endotoxin-induced inflammation in rat lung.
    Escofier N; Boichot E; Germain N; Silva PM; Martins MA; Lagente V
    Fundam Clin Pharmacol; 1999; 13(1):96-101. PubMed ID: 10027094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of phosphodiesterase isoenzyme inhibitors on cutaneous inflammation in the guinea-pig.
    Teixeira MM; Rossi AG; Williams TJ; Hellewell PG
    Br J Pharmacol; 1994 May; 112(1):332-40. PubMed ID: 8032659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.
    Underwood DC; Osborn RR; Novak LB; Matthews JK; Newsholme SJ; Undem BJ; Hand JM; Torphy TJ
    J Pharmacol Exp Ther; 1993 Jul; 266(1):306-13. PubMed ID: 8392555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of selective phosphodiesterase inhibitors on platelet-activating factor- and antigen-induced airway hyperreactivity, eosinophil accumulation, and microvascular leakage in guinea pigs.
    Ortiz JL; Vallés JM; Martí-Cabrera M; Cortijo J; Morcillo EJ
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jan; 353(2):200-6. PubMed ID: 8717161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor.
    Prabhakar U; Lipshutz D; Bartus JO; Slivjak MJ; Smith EF; Lee JC; Esser KM
    Int J Immunopharmacol; 1994 Oct; 16(10):805-16. PubMed ID: 7843852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of bronchospasm and ozone-induced airway hyperresponsiveness in the guinea-pig by CDP840, a novel phosphodiesterase type 4 inhibitor.
    Holbrook M; Gozzard N; James T; Higgs G; Hughes B
    Br J Pharmacol; 1996 Jul; 118(5):1192-200. PubMed ID: 8818343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lipopolysaccharide-induced pulmonary edema by isozyme-selective phosphodiesterase inhibitors in guinea pigs.
    Howell RE; Jenkins LP; Howell DE
    J Pharmacol Exp Ther; 1995 Nov; 275(2):703-9. PubMed ID: 7473157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of neurally mediated nonadrenergic, noncholinergic contractions of guinea pig bronchus by isozyme-selective phosphodiesterase inhibitors.
    Undem BJ; Meeker SN; Chen J
    J Pharmacol Exp Ther; 1994 Nov; 271(2):811-7. PubMed ID: 7965800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rolipram inhibits PAF-induced airway microvascular leakage in guinea-pig: a comparison with milrinone and theophylline.
    Ortiz JL; Cortijo J; Vallés JM; Morcillo EJ
    Fundam Clin Pharmacol; 1992; 6(6):247-9. PubMed ID: 1487228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of phosphodiestrase 4 inhibitor (rolipram) on experimental allergic asthma-guinea pig model].
    Nejman-Gryz P; Grubek-Jaworska H; Glapińiski J; Chazan R
    Pneumonol Alergol Pol; 2006; 74(1):106-12. PubMed ID: 17175988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic lipopolysaccharide exposure on airway function, cell infiltration, and nitric oxide generation in conscious guinea pigs: effect of rolipram and dexamethasone.
    Toward TJ; Broadley KJ
    J Pharmacol Exp Ther; 2001 Jul; 298(1):298-306. PubMed ID: 11408555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of leukotriene D4 and tumor necrosis factor on lipopolysaccharide-induced airway hyperresponsiveness in guinea pigs.
    Uno T; Tanaka H; Nakai N; Nagai H
    Biol Pharm Bull; 1997 Apr; 20(4):332-7. PubMed ID: 9145204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4.
    Hughes B; Howat D; Lisle H; Holbrook M; James T; Gozzard N; Blease K; Hughes P; Kingaby R; Warrellow G; Alexander R; Head J; Boyd E; Eaton M; Perry M; Wales M; Smith B; Owens R; Catterall C; Lumb S; Russell A; Allen R; Merriman M; Bloxham D; Higgs G
    Br J Pharmacol; 1996 Jul; 118(5):1183-91. PubMed ID: 8818342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.